Results for tag: "Aerosol Delivery Device"

The Aerosol Delivery Device market is composed of two main categories: Inhalers and Nebulisers. Inhalers are devices that deliver medication directly to the lungs in the form of a mist or spray. They are typically used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Nebulisers are devices that convert liquid medication into a fine mist that can be inhaled. They are typically used to treat more severe respiratory conditions, such as cystic fibrosis. Inhalers and nebulisers are both used to deliver medication to the lungs, but they differ in terms of their size, portability, and ease of use. Inhalers are typically smaller and more portable than nebulisers, making them more convenient for patients to carry and use. Inhalers also require less coordination and effort to use than nebulisers, making them easier for patients to use. Some companies in the Aerosol Delivery Device market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, and Teva Pharmaceuticals. Other companies include 3M, Philips, and Omron Healthcare. Show Less Read more